Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 15(11): e49280, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38143669

ABSTRACT

Background and objective It is crucial to make early differentiation between coronavirus disease 2019 (COVID-19) and seasonal influenza infections at the time of a patient's presentation to the emergency department (ED). In light of this, this study aimed to identify key epidemiological, initial laboratory, and radiological differences that would enable early recognition during co-circulation. Methods This was a retrospective, observational cohort study. All adult patients presenting to our ED at the Watford General Hospital, UK, with a laboratory-confirmed diagnosis of COVID-19 (2019/20) or influenza (2018/19) infection were included in this study. Demographic, laboratory, and radiological data were collected. Binary logistic regression was employed to determine features associated with COVID-19 infection rather than influenza. Results Chest radiographs suggestive of viral pneumonitis and older age (≥80 years) were associated with increased odds of having COVID-19 [odds ratio (OR): 47.00, 95% confidence interval (CI): 21.63-102.13 and OR: 64.85, 95% CI: 19.96-210.69 respectively]. Low eosinophils (<0.02 x 109/L) were found to increase the odds of COVID-19 (OR: 2.12, 95% CI: 1.44-3.10, p<0.001). Conclusions Gaining awareness about the epidemiological, biological, and radiologic presentation of influenza-like illness can be useful for clinicians in ED to differentiate between COVID-19 and influenza. This study showed that older age, eosinopenia, and radiographic evidence of viral pneumonitis significantly increase the odds of having COVID-19 compared to influenza. Further research is needed to determine if these findings are affected by acquired or natural immunity.

2.
Clin Appl Thromb Hemost ; 28: 10760296211064898, 2022.
Article in English | MEDLINE | ID: mdl-35043658

ABSTRACT

INTRODUCTION: The pathophysiology of pulmonary embolism (PE) represents complex, multifactorial processes involving blood cells, vascular endothelium, and the activation of inflammatory pathways. Platelet (P), endothelial (E), and leukocyte (L)-selectin molecules may play an important role in PE pathophysiology. We aimed to profile the biomarkers of inflammation, including selectins in PE patients, and compare them to healthy individuals. MATERIALS AND METHODS: 100 acute PE patients and 50 controls were included in this case control study. ELISA methods were used to quantify levels of selectins, inflammatory, and hemostatic biomarkers. RESULTS: In PE patients, levels of selectin molecules as compared to controls convey increased P-selectin levels (95 ng/mL vs 40 ng/mL, p < .0001) and decreased L-selectin levels (1468 ng/mL vs 1934 ng/mL, p < .0001). Significant correlations were found between selectins and Plasminogen Activating Inhibitor-1 (PAI-1), Tumor Necrosis Factor-a (TNFa), and D-dimer. Fold change between selectins and controls is compared to other biomarkers, illustrating degrees of change comparable to TNFa, alpha-2-antiplasmin, and microparticles. L-selectin levels are inversely associated with all-cause-mortality in PE patients, (p = .040). CONCLUSION: These studies suggest that various thrombo-inflammatory biomarkers are elevated in PE patients. Furthermore, L-selectin levels are inversely associated with mortality outcomes.


Subject(s)
Hemostasis/physiology , Inflammation/blood , Pulmonary Embolism/blood , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Endothelium, Vascular/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
3.
Clin Appl Thromb Hemost ; 27: 10760296211052292, 2021.
Article in English | MEDLINE | ID: mdl-34846193

ABSTRACT

Pulmonary embolism (PE) clinical manifestations vary widely, and that scope is not fully captured by current all-cause mortality risk models. PE is associated with inflammatory, coagulation, and hemostatic imbalances so blood cellular indices may be prognostically useful. Complete blood count (CBC) data may improve current risk models like the simplified pulmonary embolism severity index (sPESI) for all-cause mortality, offering greater accuracy and analytic ability. Acute PE patients (n = 228) with confirmatory diagnostic imaging were followed for all-cause mortality. Blood cellular indices were assessed for association to all-cause mortality and were supplemented into sPESI using multivariate logistic regression. Multiple blood cellular indices were found to be significantly associated with all-cause mortality in acute PE. sPESI including red cell distribution width, hematocrit and neutrophil-lymphocyte ratio had better predictive ability as compared to sPESI alone (AUC: 0.852 vs 0.754). Blood cellular indices contribute an inflammatory and hemodynamic perspective not currently included in sPESI. CBC with differential is a widely used, low-cost test that can augment current risk stratification tools for all-cause mortality in acute PE patients.


Subject(s)
Decision Support Techniques , Hematologic Tests , Pulmonary Embolism/diagnosis , Aged , Cause of Death , Erythrocyte Indices , Female , Hematocrit , Humans , Lymphocyte Count , Male , Middle Aged , Predictive Value of Tests , Prognosis , Prospective Studies , Pulmonary Embolism/blood , Pulmonary Embolism/mortality , Pulmonary Embolism/therapy , Retrospective Studies , Risk Assessment , Risk Factors
4.
J Egypt Public Health Assoc ; 96(1): 19, 2021 Jul 06.
Article in English | MEDLINE | ID: mdl-34228245

ABSTRACT

BACKGROUND: Few data were documented about risk factors for lower limb varicose veins (LLVV) among Egyptian population. Identifying modifiable risk factors is crucial to plan for prevention. The current research aims to study the epidemiological, life style, and occupational factors associated with LLVV in a sample of Egyptian population. METHODS: A case control study was adopted. Cases with LLVV (n = 150) were compared with controls (n = 150). Data was collected using an interview questionnaire and clinical assessment. Data was analyzed using the univariate and multivariate logistic regression analyses. RESULTS: According to multivariate analysis among all participants (n = 300), the odds of LLVV was 59.8 times greater for those who frequently lift heavy objects (95% CI = 6.01, 584.36) and 6.95 times higher for those who drink < 5 cups of water/day (95% CI = 2.78, 17.33). Moreover, it was 4.27 times greater for those who infrequently/never consume fiber-rich foods (95% CI = 1.95, 9.37) and 3.65 times greater for those who stand > 4 h/day (95% CI = 1.63, 8.17). Additionally, odds of LLVV was 3.34 times greater for those who report irregular defecation habit (95% CI = 1.68, 6.60), and 2.86 times higher for those who sleep < 8 h/day (95% CI = 1.14, 7.16), and 2.53 times higher for smokers compared with ex-smokers/non-smokers (95% CI = 1.15, 5.58). In addition, a standing posture at work was an independent predictor of LLVV among ever employed participants (n = 234) in the current study (OR = 3.10; 95% CI = 1.02, 9.38). CONCLUSIONS: This study highlighted seven modifiable independent predictors of LLVV mostly related to the life style, namely, frequent lifting of heavy objects, drinking < 5 cups of water/day, infrequent/no consumption of fiber-rich food, standing more than 4 h/day, irregular defecation habit, sleeping less than 8 h/day, and smoking. These findings provide a basis to design an evidence-based low-cost strategy for prevention of LLVV among Egyptian population.

5.
Clin Appl Thromb Hemost ; 27: 10760296211014964, 2021.
Article in English | MEDLINE | ID: mdl-34013785

ABSTRACT

Pulmonary embolism (PE) patients have an increased prevalence and incidence of atrial fibrillation (AF). Because comorbid AF increases risk of morbidity and mortality, we sought to investigate the role of thrombo-inflammatory biomarkers in risk stratifying patients who experience an acute PE episode. Study participants were enrolled from a Pulmonary Embolism Response Team (PERT) registry between March 2016 and March 2019 at Loyola University Medical Center and Gottlieb Memorial Hospital. This cohort was divided into 3 groups: PE patients with a prior diagnosis of AF (n = 8), PE patients with a subsequent diagnosis of AF (n = 11), and PE patients who do not develop AF (n = 71). D-dimer, CRP, PAI-1, TAFIa, FXIIIa, A2A, MP, and TFPI were profiled using the ELISA method. All biomarkers were significantly different between controls and PE patients (P < 0.05). Furthermore, TFPI was significantly elevated in PE patients who subsequently developed AF compared to PE patients who did not develop AF (157.7 ± 19.0 ng/mL vs. 129.0 ± 9.3 ng/mL, P = 0.0386). This study suggests that thrombo-inflammatory biomarkers may be helpful in indicating an acute PE episode. Also, elevated TFPI levels may be associated with an increased risk of developing AF after a PE.


Subject(s)
Atrial Fibrillation/physiopathology , Biomarkers/metabolism , Inflammation/complications , Pulmonary Embolism/physiopathology , Thrombosis/complications , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors
6.
Antibiotics (Basel) ; 9(9)2020 Sep 11.
Article in English | MEDLINE | ID: mdl-32933028

ABSTRACT

Inhibitors of the bacterial enzyme dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18) hold promise as antibiotics with a new mechanism of action. Herein we describe the discovery of a new series of indoline sulfonamide DapE inhibitors from a high-throughput screen and the synthesis of a series of analogs. Inhibitory potency was measured by a ninhydrin-based DapE assay recently developed by our group. Molecular docking experiments suggest active site binding with the sulfonamide acting as a zinc-binding group (ZBG).

7.
Pak J Pharm Sci ; 32(2): 637-646, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31081777

ABSTRACT

Ivermectin (IVM) is a broad-spectrum anti-parasite agent. It is extremely toxic to fish and aquatic life. Some animals showed reduction in the fertility, the number of variable fetuses and sperm count following treatment with (IVM). Therefore, the objective of the current work was to investigate the mutagenicity of IVM on meiotic chromosomes of mice. The variations in protein fractions of blood serum were also studied using sodium Dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE).Animals received single injections only of 200ug/kg b.wt. for meiotic chromosome study. Whereas single and double treatment for serum protein examinations. Analysis of the treated samples revealed significant increase in meiotic aberrations, 33.83% vs 5.8% for the control (P < 0.001). Single injection induced much variation in the percentage area of the separated protein than that produced by double treatment. These findings supports the mutagenicity of IVM, accordingly cautious use of IVM is advisable.


Subject(s)
Blood Proteins/metabolism , Ivermectin/toxicity , Mutagens/toxicity , Spermatocytes/drug effects , Animals , Blood Proteins/analysis , Chromosome Aberrations , Electrophoresis, Polyacrylamide Gel , Male , Mice , Mutagenicity Tests , Spermatocytes/physiology
8.
Pak J Pharm Sci ; 32(1): 89-93, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30772795

ABSTRACT

In the present study, genotoxic effect of methyl tert butyl ether MTBE was analyzed by measuring chromosomal aberrations (CAs) in bone marrow cells of rats. Rats administered MTBE orally at 800, 1600mg/kg/day in corn oil for 14 and 28 consecutive days. Control rats received injection of distilled water. An additional two groups of rats received corn oil and served as vehicle controls. Treatment of corn oil for 14 and 28 days failed to induce chromosomal aberrations. The highest percentage of chromosomal aberrations was produced by the two tested dose 14 days after treatment. The most structural aberrations were Robertsonion translocations, deletion, dicentric, end to end association while, ring, acentric fragment and gaps were rare. The present results indicate that MTBE is harmful to mammalian genetic material.


Subject(s)
Bone Marrow Cells/drug effects , Chromosome Aberrations/chemically induced , Methyl Ethers/toxicity , Animals , Bone Marrow Cells/pathology , Dose-Response Relationship, Drug , Male , Mutagenicity Tests , Rats , Risk Assessment , Time Factors
9.
Pak J Pharm Sci ; 31(6): 2471-2477, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30530448

ABSTRACT

Ivermectin, a broad-spectrum anti-parasitic agent first used in veterinary medicine, is active against numerous species of helminths and arthropods. In this study, we aimed to demonstrate the effects of administration of ivermectin on secondary meiotic division and serum total proteins. Male mice treated with single injections of 200ug/kg b.w. IVM. Meiotic chromosomes were prepared after 6 hours, 2, 5, 10 and 12 days to cover the different phases of meiotic division. Blood samples were collected after 1, 7 and 14 days of the last injection to determine total protein content. Euploidy (haploid no which equal 20 chromosomes) was recorded in 8.6 of the scored cells of secondary spermatocytes. Hyperhaploid (metaphases that include more than 20 and less than 23 chromosomes) was also considered. A total of 46 hyperhaploid metaphases were registered for 2100 examined cells. The hyper-haploidy index was 2.49% versus 0.8% for the control. Acentric fragments were occasionally occurred. After 1 and 7 days, single injections of IVM led to elevate the total protein content than that resulted after double treatment. However, the data obtained after 14 days were closed together. In conclusion, IVM is produced a considerable signs of chromosomal damage to germ cells. So, the cytogenetic studies revealed high clastogenicity of the drug. On the other hand, the differences in total protein concentration obtained between treated and control samples indicate genotoxic potential for IVM.


Subject(s)
Antiparasitic Agents/toxicity , Blood Proteins/metabolism , Ivermectin/toxicity , Meiosis/drug effects , Ploidies , Spermatocytes/drug effects , Spermatogenesis/drug effects , Animals , Male , Mice , Spermatocytes/metabolism , Spermatocytes/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...